AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.

AngioDynamics Inc.

In a report released today, John Young CFA from Canaccord Genuity reiterated a Buy rating on AngioDynamics, with a price target of $16.00. Young CF...

Canaccord Genuity Remains a Buy on AngioDynamics (ANGO)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on OnKure Therapeutics (OKUR) and AngioDynamics (ANGO) ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

Angiodynamics, Inc. (($ANGO)) has held its Q3 earnings call. Read on for the main highlights of the call. AngioDynamics’ latest earnings call struc...

Current Quarter	$-0.07	Next Quarter	$-0.06
Current Year	$-0.2	Next Year	$-0.08
QoQ Growth	+14.3%	YoY Growth	+60.0%
3Y EPS CAGR	-6.9%	Target Price	$18.00
Consensus	Buy	Upside	+60.6%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ANGO	$11.21	+0.99%	40.76K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ANGO	$11.21	+1.0%	40.76K
3
4
5
6

ANGO

ANGO

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get AngioDynamics Inc. Data in Excel

Get AngioDynamics Inc. Data in Excel